NPPA and limited cutaneous systemic sclerosis: Three biomolecules proposed as biomarkers for differentiating between diffuse and limited systemic sclerosis are produced by progenitor myelopoietic cells (SuPAR), the muscle of the left atrium of the heart (MR-proANP), and macrophages (GDF-15).